CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics to Announce Third Quarter Results on November 2, 2023

23 10 2023 15:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Provides Update on Cardiac Myosin Inhibitor Programs and Plans to Build a Specialty Cardiology Franchise at Virtual Investor & Analyst Day

19 10 2023 06:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics Presents Baseline Characteristics From SEQUOIA-HCM at the HCM Society Scientific Sessions

06 10 2023 11:45:00 提供 Nasdaq GlobeNewswire

Cytokinetics to Host Virtual Investor & Analyst Day on October 19, 2023

05 10 2023 15:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

04 10 2023 08:49:12 提供 NetDania Notify

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

03 10 2023 15:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

03 10 2023 09:20:20 提供 NetDania Notify

Cytokinetics Announces Upcoming Presentations at the 2023 HCMS Scientific Sessions and the HFSA Annual Scientific Meeting

02 10 2023 15:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

02 10 2023 10:26:54 提供 NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

28 9 2023 08:47:33 提供 NetDania Notify

Cytokinetics Announces Call for Proposals for Its Sixth Annual Communications Grant Program

28 9 2023 06:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

27 9 2023 12:39:42 提供 NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

26 9 2023 08:46:14 提供 NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

25 9 2023 08:49:39 提供 NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

21 9 2023 10:24:33 提供 NetDania Notify

Cytokinetics to Participate in Upcoming Investor Conferences

07 9 2023 15:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Start of ACACIA-HCM, a Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

06 9 2023 06:30:00 提供 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 9 2023 15:00:00 提供 Nasdaq GlobeNewswire

Cytokinetics Reports Second Quarter 2023 Financial Results

03 8 2023 15:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

02 8 2023 08:57:28 提供 NetDania Notify